Skip to content

Clinical trials

Phase 2/3 trials in Bosnia and Herzegovina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Bosnia and Herzegovina Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20111
20161
20181
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
Astellas Pharma Europe B.V.1
AtheroGenics1
Auron Healthcare GmbH1
Bosnalijek D.D1
Janssen Research & Development, LLC1
Synta Pharmaceuticals Corp.1
University of Mostar1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms2
COVID-191
Carcinoma, Non-Small-Cell Lung1
Colitis, Ulcerative1
Colonic Neoplasms1
Crohn Disease1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Esophageal Neoplasms1
Gallbladder Neoplasms1

Trials

Showing 51 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.